Merck · 2 hours ago
Associate Director, Data Science, Neuroscience Biomarker Discovery
Cambridge, MA
Full-time
Hybrid
Lead/Staff, Director/Executive
$160K/yr - $251K/yr
5+ years expMerck is seeking an Associate Director in their Data, AI & Genome Sciences Department to lead efforts in biomarker discovery for neuroscience. The role involves utilizing advanced data-driven approaches and collaborating with cross-functional teams to analyze and integrate proteomics data for drug discovery.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead proteomics data analysis efforts to drive precision biomarker discovery, inform translational strategies, and enable data-driven decision-making of multiple Neuroscience drug discovery programs
Formulate and drive integrative analysis of biofluid proteomics data with other omics data modalities and across multiple patient cohorts
Collaborate with AI/ML scientists to develop and incorporate new methodologies into existing frameworks to enhance data analysis capabilities
Collaborate with data generation, analytics and IT teams to build platforms for data sharing and knowledge dissemination
Work with experimental biologists, functional area experts, and clinical scientists to support drug discovery and development programs at various stages
Provide data science / computational biology input into research strategy, experimental design, provide data analytical input, and assist in interpreting results from both in-vitro and in-vivo studies
Communicate data analytic results effectively to project teams, key stakeholders, as well as the wider scientific community through written and verbal means, including proposals for further experiments, presentations at internal and external meetings, and publications in leading journals
Qualification
Required
PhD in Data Science, Computational Biology, Computer Science, Neuroscience, Bioinformatics, Biostatistics, Biophysics, Genomics, or a related STEM discipline, with a minimum of 5 years of experience in multimodal data analytics OR MS and 8+ years of experience
Demonstrated expertise in data science, computational biology, machine learning, omics data analysis, integration, and interpretation
Extensive experience with QC and analysis of data generated with various proteomics platforms (Olink/SomaScan/LC-MS/Seer)
Proficient in one or more programming languages (e.g., Python, R), HPC environments and/or cloud-based platforms, as well as version control systems, (e.g., Github)
Ability to critically evaluate and apply novel data analysis methods in translational applications
Strong problem-solving skills, self-motivated, attention to detail, and ability to handle multiple projects
Extensive experience to conduct research in a collaborative environment and excellent ability to communicate scientific questions, methodologies, findings and insights
Track record of contributions to peer-reviewed publications in the field of data science or computational biology
Preferred
Outstanding scientific caliber with strong capabilities to identify key analytic questions and formulate rigorous data analytic plans to address critical scientific needs of drug discovery programs
Familiarity with public databases, repositories, and consortia for neurological disease research, especially those include biofluid proteomics data
Good understanding of neurobiology, particularly neurodegenerative diseases and pain biology
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Betty Larson
Executive Vice President and Chief Human Resources Officer
Dean Li
Executive Vice President and President, Merck Research Laboratories
Recent News
2026-01-24
The Motley Fool
2026-01-24
2026-01-23
Company data provided by crunchbase